MedTrace Logo

Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant

NCT03389360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-03-19

No results posted yet for this study

Summary

, the study aimed at assessing the frequency of rising procalcitonin associated with infectious complications in immunosuppressed LDLTRx.

Conditions

  • Liver Transplant Infection

Interventions

DIAGNOSTIC_TEST

procalcitonin

assessing the frequency of rising procalcitonin associated with infectious complications in immunosuppressed LDLTRx.

Sponsors & Collaborators

  • National Hepatology & Tropical Medicine Research Institute

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-15
Primary Completion
2018-12-20
Completion
2019-02-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03389360 on ClinicalTrials.gov